SciClone Pharmaceuticals (Holdings) Limited approved a final dividend of HKD 0.39 per ordinary share for the year ended December 31, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
18.52 HKD | +0.33% | +0.54% | +33.05% |
May. 16 | Sciclone Pharmaceuticals Limited Announces Change of Address of Principal Place of Business in Hong Kong | CI |
Apr. 18 | Sciclone Pharmaceuticals to Dispatch Privatization Documents by May 31 | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+33.05% | 1.43B | |
-1.54% | 90.85B | |
-1.05% | 39.02B | |
-11.20% | 33.46B | |
+61.85% | 26.38B | |
-20.75% | 14.51B | |
-6.35% | 13.22B | |
-11.42% | 11.65B | |
-47.67% | 10.57B | |
+5.99% | 9.23B |
- Stock Market
- Equities
- 6600 Stock
- News SciClone Pharmaceuticals (Holdings) Limited
- SciClone Pharmaceuticals Limited Approves a Final Dividend for the Year Ended December 31, 2022